Fabian Carlos Castillo-Solís

Mr. Fabian Carlos Castillo-Solís

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2023 in Molecules
Verified
Journal Article
Open access
PDF file
CRCristina Jeanneth Rodríguez-Pólit
Cristina Jeanneth Rodríguez-Pólit
RGRebeca Gonzalez-Pastor
Rebeca Gonzalez-Pastor
JHJorge Heredia-Moya
Jorge Heredia-Moya
Saskya CarreraSaskya Carrera
Saskya Carrera
Fabian Carlos Castillo-SolísFabian Carlos Castillo-Solís
Fabian Carlos Castillo-Solís
Linda GuamanLinda Guaman
Linda Guaman
Pollen, a remarkably versatile natural compound collected by bees for its abundant source of proteins and nutrients, represents a rich reservoir of diverse bioactive compounds with noteworthy chemical and therapeutic potential. Its extensive biological effects have been known and exploited since ancient times. Today, there is an increased interest in finding natural compounds against oxidative stress, a factor that contributes to various diseases. Recent research has unraveled a multitude of biological activities associated with bee pollen, ranging from antioxidant, anti-inflammatory, antimicrobial, and antifungal properties to potential antiviral and anticancer applications. Comprehending the extensive repertoire of biological properties across various pollen sources remains challenging. By investigating a spectrum of pollen types and their chemical composition, this review produces an updated analysis of the bioactive constituents and the therapeutic prospects they offer. This review emphasizes the necessity for further exploration and standardization of diverse pollen sources and bioactive compounds that could contribute to the development of innovative therapies.

Verified
Journal Article
Open access
PDF file
HOHenrry Marcelo Osorio
Henrry Marcelo Osorio
Fabian Carlos Castillo-SolísFabian Carlos Castillo-Solís
Fabian Carlos Castillo-Solís
SBSelena Yanina Barragán
Selena Yanina Barragán
CRCristina Jeanneth Rodríguez-Pólit
Cristina Jeanneth Rodríguez-Pólit
RGRebeca Gonzalez-Pastor
Rebeca Gonzalez-Pastor
Cancer therapy is constantly evolving, with a growing emphasis on targeted and efficient treatment options. In this context, graphene quantum dots (GQDs) have emerged as promising agents for precise drug and gene delivery due to their unique attributes, such as high surface area, photoluminescence, up-conversion photoluminescence, and biocompatibility. GQDs can damage cancer cells and exhibit intrinsic photothermal conversion and singlet oxygen generation efficiency under specific light irradiation, enhancing their effectiveness. They serve as direct therapeutic agents and versatile drug delivery platforms capable of being easily functionalized with various targeting molecules and therapeutic agents. However, challenges such as achieving uniform size and morphology, precise bandgap engineering, and scalability, along with minimizing cytotoxicity and the environmental impact of their production, must be addressed. Additionally, there is a need for a more comprehensive understanding of cellular mechanisms and drug release processes, as well as improved purification methods. Integrating GQDs into existing drug delivery systems enhances the efficacy of traditional treatments, offering more efficient and less invasive options for cancer patients. This review highlights the transformative potential of GQDs in cancer therapy while acknowledging the challenges that researchers must overcome for broader application.

19 October 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
CRCristina Jeanneth Rodríguez-Pólit
Cristina Jeanneth Rodríguez-Pólit
RGRebeca Gonzalez-Pastor
Rebeca Gonzalez-Pastor
JHJorge Heredia-Moya
Jorge Heredia-Moya
Saskya CarreraSaskya Carrera
Saskya Carrera
Fabian Carlos Castillo-SolísFabian Carlos Castillo-Solís
Fabian Carlos Castillo-Solís
Linda GuamanLinda Guaman
Linda Guaman
Pollen, a remarkably versatile natural compound collected by bees for its abundant source of proteins and nutrients, represents a rich reservoir of diverse bioactive compounds with noteworthy chemical and therapeutic potential. Its large range of biological effects has been known and exploited since ancient times. Today, there is an increased interest in finding natural compounds agaisnt oxidative stress, a factor that contributes to various diseases. Recent research has unraveled a multitude of biological activities associated with bee pollen, ranging from antioxidant, anti-inflammatory, antimicrobial, and antifungal properties to potential antiviral and anticancer applications. Comprehending the extensive repertoire of biological properties across various pollen sources remains a challenge. By investigating a spectrum of pollen types and their chemical composition, this review produces an updated analysis of the bioactive constituents and the therapeutic prospects they offer. The findings of this review emphasize the necessity for further exploration and standardization of diverse pollen sources and bioactive compounds that could contribute to the development of innovative therapies.

21 November 2024 in Molecules
Verified
Journal Article
Open access
PDF file
Carlos Barba-OstriaCarlos Barba-Ostria
Carlos Barba-Ostria
RGRebeca Gonzalez-Pastor
Rebeca Gonzalez-Pastor
Fabian Carlos Castillo-SolísFabian Carlos Castillo-Solís
Fabian Carlos Castillo-Solís
Saskya CarreraSaskya Carrera
Saskya Carrera
Orestes LópezOrestes López
Orestes López
Linda GuamanLinda Guaman
Linda Guaman
Anthocyanins, widely recognized for their antioxidant properties and potential health benefits, are highly susceptible to degradation due to environmental factors such as light, temperature, and pH leading to reduced bioavailability and efficacy. Microencapsulation, which involves entrapment in a matrix to enhance stability and bioavailability. This study aims to investigate the bioactive properties of microencapsulated anthocyanins derived from Vaccinium floribundum (Andean blueberry) and Rubus glaucus (Andean blackberry). The extracts from V. floribundum and R. glaucus were microencapsulated using maltodextrin as the carrier agent due to its film-forming properties and effectiveness in stabilizing sensitive compounds through a spray-drying process. The microcapsules were characterized using Fourier Transform Infrared Spectroscopy (FTIR) and Scanning Electron Microscopy (SEM) to assess their chemical and morphological properties. The biological activities of these microencapsulated anthocyanins were evaluated using in vitro assays for their antibacterial, antioxidant, and anti-inflammatory effects. The results indicated enhanced bioactivity of the microencapsulated anthocyanins, suggesting their potential use in developing functional foods and pharmaceuticals. This study provides valuable insights into the effectiveness of microencapsulation in preserving anthocyanins’ functional properties and enhancing their health-promoting effects, highlighting the potential for application in the food and pharmaceutical industries.

2 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Carlos Barba-OstriaCarlos Barba-Ostria
Carlos Barba-Ostria
RGRebeca Gonzalez-Pastor
Rebeca Gonzalez-Pastor
Fabian Carlos Castillo-SolísFabian Carlos Castillo-Solís
Fabian Carlos Castillo-Solís
Saskya CarreraSaskya Carrera
Saskya Carrera
Orestes LópezOrestes López
Orestes López
Linda GuamanLinda Guaman
Linda Guaman
Anthocyanins, known for their antioxidant properties and potential health benefits, are prone to degradation due to environmental factors such as light, temperature, and pH. Microencapsulation, a technique involving the entrapment of anthocyanins in a protective matrix, is used to enhance their stability and bioavailability. This study investigates the bioactive properties of microencapsulated anthocyanins derived from Vaccinium floribundum (Andean blueberry) and Rubus glaucus (Andean blackberry). The extracts from V. floribundum and R. glaucus were microencapsulated using maltodextrin as the carrier agent through a spray-drying process. The microcapsules were characterized using Fourier Transform Infrared Spectroscopy (FTIR) and Scanning Electron Microscopy (SEM) to assess their chemical and morphological properties. The biological activities of these microencapsulated anthocyanins were evaluated for their antibacterial, antioxidant, and anti inflammatory effects. The results demonstrated enhanced bioactivity of the microencapsulated anthocyanins, highlighting their potential use in developing functional foods and pharmaceuticals. This study provides insights into the effectiveness of microencapsulation in preserving anthocyanins' functional properties and enhancing their health-promoting effects.

16 September 2026 in Molecules
Verified
Journal Article
Open access
PDF file
Fabian Carlos Castillo-SolísFabian Carlos Castillo-Solís
Fabian Carlos Castillo-Solís
Juan A. Puente-PinedaJuan A. Puente-Pineda
Juan A. Puente-Pineda
DCDiana Raquel Celi
Diana Raquel Celi
HOHenrry Marcelo Osorio
Henrry Marcelo Osorio
Elena Del Rocío Coyago CruzElena Del Rocío Coyago Cruz
Elena Del Rocío Coyago Cruz
RGRebeca Gonzalez-Pastor
Rebeca Gonzalez-Pastor
Lepidium meyenii and Bactris gasipaes are traditionally consumed plant foods with documented antioxidant and inflammation-related activities and emerging evidence of cancer-related biological effects. Accordingly, we compared the antitumor-relevant activity of these chemically distinct extracts and evaluated the effect of microencapsulation. Liquid extracts were chemically characterized, spray-dried with maltodextrin- or maltodextrin–gum arabic, and evaluated in tumor and non-tumor cell models, with antioxidant and inflammation-related endpoints as complementary responses; L. meyenii was further examined by bioactivity-guided fractionation. Chemical characterization confirmed that L. meyenii was enriched in organic acids, phenolics, and alkaloids, whereas B. gasipaes was dominated by carotenoids. B. gasipaes liquid extract showed lower IC50 values (0.27–0.63 mg/mL), whereas L. meyenii liquid extract showed higher calculated therapeutic indices (2.28–3.64). Both extracts showed encapsulation efficiencies above 97%, with microencapsulation generally reducing antiproliferative potency. Bioactivity-guided fractionation associated the strongest tumor-cell responses with L. meyenii fractions containing signals putatively annotated as lepidilines A, B, and D. Additionally, L. meyenii extract reduced LPS-induced nitric oxide production without reproducing a broad LPS-like transcriptional response. These findings support further studies to evaluate enriched constituents, clarify mechanisms across broader cell models, and explore spray-dried carrier behavior during storage and reconstitution.